Skip to main content

Site notifications

REVONTO dantrolene sodium for injection 20mg/vial

Section 19A approved medicine
REVONTO dantrolene sodium for injection 20mg/vial
Section 19A approval holder
Link Medical Products Pty Ltd ABN 730 109 715 16
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
DANTRIUM 20mg powder for injection - ARTG 14435
Indication(s)

Indicated, along with appropriate supportive measures, for the management of the fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crisis. It should be administered by intravenous injection as soon as the malignant hyperthermia reaction is recognised (i.e. tachycardia, tachypnea, central venous desaturation, hypercarbia, metabolic acidosis, skeletal muscle rigidity, increased utilisation of anaesthesia circuit carbon dioxide absorber, cyanosis and mottling of the skin, and, in many cases, fever).

Images
Picture of REVONTO dantrolene sodium for injection 20mg/vial

Help us improve the Therapeutic Goods Administration site